Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk

Abstract

BackgroundThe risk of sexual transmission of HIV-1 is strongly associated with the level of HIV-1 RNA in plasma making reduction in HIV-1 plasma levels an important target for HIV-1 prevention interventions. A quantitative understanding of the relationship of plasma HIV-1 RNA and HIV-1 transmission risk could help predict the impact of candidate HIV-1 prevention interventions that operate by reducing plasma HIV-1 levels, such as antiretroviral therapy (ART), therapeutic vaccines, and other non-ART interventions.Methodology/Principal FindingsWe use prospective data collected from 2004 to 2008 in East and Southern African HIV-1 serodiscordant couples to model the relationship of plasma HIV-1 RNA levels and heterosexual transmission risk with confirmation of HIV-1 transmission events by HIV-1 sequencing. The model is based on follow-up of 3381 HIV-1 serodiscordant couples over 5017 person-years encompassing 108 genetically-linked HIV-1 transmission events. HIV-1 transmission risk was 2.27 per 100 person-years with a log-linear relationship to log10 plasma HIV-1 RNA. The model predicts that a decrease in average plasma HIV-1 RNA of 0.74 log10 copies/mL (95% CI 0.60 to 0.97) reduces heterosexual transmission risk by 50%, regardless of the average starting plasma HIV-1 level in the population and independent of other HIV-1-related population characteristics. In a simulated population with a similar plasma HIV-1 RNA distribution the model estimates that 90% of overall HIV-1 infections averted by a 0.74 copies/mL reduction in plasma HIV-1 RNA could be achieved by targeting this reduction to the 58% of the cohort with plasma HIV-1 levels ≥4 log10 copies/mL.Conclusions/SignificanceThis log-linear model of plasma HIV-1 levels and risk of sexual HIV-1 transmission may help estimate the impact on HIV-1 transmission and infections averted from candidate interventions that reduce plasma HIV-1 RNA levels.

Estimation of the Overall Treatment Effect in the Presence of Interference in Cluster-Randomized Trials of Infectious Disease Prevention

“…Of these, only the last will have a protective effect for the individual receiving the treatment. The rest operate by treating those who are already infected, thus reducing their viral burden, and hence the probability of onward transmission (Quinn et al 2000;Attia et al 2009;Lingappa et al 2010;Novitsky and Essex 2012). Therefore, the bulk of the effect will be due to indirect mechanisms.…”

Biology as Population Dynamics: Heuristics for Transmission Risk

“…Emotional and physical trauma associated with violence could also affect immunity to infectious diseases, but the relationship between stress and the immune system is complex: for instance, although chronic stress has a negative impact on immune function, short-term stress may boost immune activity, including natural-killer-cell activity and leucocyte release. 31,32 Traditionally, modelling is dichotomized into 'deterministic' and 'stochastic' (probabilistic/statistical) rules. The former tend to capture abstract 'rules', and also the emergent or average behaviour of systems of sufficient size.…”

“…• The probability of transmission (male to female) is low 14,15 and approximately proportional to viral exposure dose and endocervical susceptible lymphocytes.…”

Antiretroviral therapy for prevention of HIV transmission: implications for Europe

“…The ability of ART to suppress HIV RNA is well documented [2][3][4] and many observational studies have found a strong association between plasma HIV-RNA viral load and the risk of onward transmission [5][6][7][8].…”